Fagan Associates, Inc. Baxter International Inc Transaction History

Fagan Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$37.88 - $43.77 $179,286 - $207,163	4,733 New	4,733 $202,000
Q2 2023 Aug 08, 2023	BUY	$39.98 - $47.68 $189,225 - $225,669	4,733 New	4,733 $215,000
Q1 2021 May 06, 2021	BUY	$76.38 - $86.03 $128,547 - $144,788	1,683 Added 51.78%	4,933 $416,000
Q3 2019 Nov 13, 2019	SELL	$81.4 - $89.78 $15,873 - $17,507	-195 Reduced 5.66%	3,250 $284,000
Q4 2018 Feb 05, 2019	SELL	$61.45 - $77.8 $15,669 - $19,839	-255 Reduced 6.89%	3,445 $227,000
Q2 2018 Aug 06, 2018	SELL	$63.43 - $75.41 $9,514 - $11,311	-150 Reduced 3.9%	3,700 $273,000
Q2 2017 Aug 07, 2017	BUY	N/A	3,850	3,850 $233,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.3B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Fagan Associates, Inc. with notifications on news.